tiprankstipranks
Trending News
More News >
Celldex Therapeutics Inc (CLDX)
NASDAQ:CLDX
US Market

Celldex (CLDX) Income Statement

Compare
1,240 Followers

Celldex Income Statement

Last quarter (Q3 2025), Celldex's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Celldex's net income was $-67.04M. See Celldex’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 7.02M$ 6.88M$ 2.36M$ 4.65M$ 7.42M
Gross Profit
$ -156.53M$ -111.13M$ -79.90M$ -48.66M$ -35.12M
Operating Expenses
$ 38.55M$ 43.41M$ 35.33M$ 22.58M$ 28.24M
Depreciation and Amortization
$ 3.18M$ 3.01M$ 2.90M$ 3.07M$ 3.93M
EBITDA
$ -191.90M$ -139.03M$ -104.20M$ -66.08M$ -45.64M
Operating Income
$ -195.08M$ -154.54M$ -115.23M$ -71.24M$ -63.35M
Other Income/Expenses
$ 37.22M$ 13.11M$ 2.91M$ 959.00K$ 2.41M
Pretax Income
$ -157.86M$ -141.43M$ -112.33M$ -70.28M$ -60.95M
Net Income
$ -157.86M$ -141.43M$ -112.33M$ -70.51M$ -59.78M
Per Share Metrics
Basic EPS
$ -2.45$ -2.92$ -2.40$ -1.64$ -2.02
Diluted EPS
$ -2.45$ -2.92$ -2.40$ -1.64$ -2.02
Weighted Average Shares Outstanding
64.39M 48.45M 46.89M 42.87M 29.64M
Weighted Average Shares Outstanding (Diluted)
64.39M 48.45M 46.89M 42.87M 29.64M
Currency in USD

Celldex Earnings and Revenue History